Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT02661958 Completed - Acne Vulgaris Clinical Trials

Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris

Start date: May 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the superiority in efficacy and assess safety and tolerability of the products S6G5T-3 and S6G5T-1 as compared to their respective active components or the vehicle for the treatment of acne.

NCT ID: NCT02656485 Completed - Acne Vulgaris Clinical Trials

A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris

Start date: August 5, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This is a single center, randomized, double-blind, placebo-controlled study in subjects with acne vulgaris.

NCT ID: NCT02656043 Completed - Acne Vulgaris Clinical Trials

A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

Start date: September 17, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Phase 1/2 study enrolling up to 60 healthy volunteers in Phase 1 followed by approximately 150 subjects with acne vulgaris in Phase 2.

NCT ID: NCT02646917 Completed - Atrophic Acne Scar Clinical Trials

SkinPen Efficacy on Acne Scars on the Face and/or Back

Start date: December 2015
Phase: N/A
Study type: Interventional

This single-center, clinical trial will take place over a 90 day course followed by 1-month and 6-month post treatment visits to assess the efficacy and tolerability of the SkinPen device when used on both men and women on the face and/or back.

NCT ID: NCT02643628 Completed - Atrophic Acne Scars Clinical Trials

A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars

Start date: October 10, 2015
Phase: N/A
Study type: Interventional

This is an open-label, randomized, multicenter, prospective trial assessing the efficacy and safety of microneedling treatment alone vs. microneedling treatment followed by treatment with Bellafill for correction of distensible atrophic facial acne scars.

NCT ID: NCT02620813 Completed - Acne Vulgaris Clinical Trials

De Novo Lipogenesis of Sebaceous Glands in Acne

Start date: October 2015
Phase: Early Phase 1
Study type: Interventional

There are two purposes of this study: 1. First, the investigators want to see what the differences are in de novo sebaceous lipid production of people with and without acne. 2. Secondly, the investigators want to know what happens to sebaceous gland de novo lipid production before and after treatment with topical tretinoin and oral isotretinoin.

NCT ID: NCT02616614 Completed - Acne Vulgaris Clinical Trials

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Start date: May 2015
Phase: Phase 3
Study type: Interventional

Actavis has developed a generic formulation of clindamycin 1.2% and benzoyl peroxide 3.75% gel. This study is designed to evaluate the safety and efficacy of this formulation in subjects with Acne Vulgaris

NCT ID: NCT02608476 Completed - Acne Vulgaris Clinical Trials

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)

Start date: November 16, 2015
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to determine the safety and efficacy of CB-03-01 cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.

NCT ID: NCT02608450 Completed - Acne Vulgaris Clinical Trials

A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)

Start date: January 21, 2016
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to determine the safety and efficacy of CB-03-01 cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.

NCT ID: NCT02604680 Completed - Acne Vulgaris Clinical Trials

A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris

Start date: October 2015
Phase: Phase 2
Study type: Interventional

The objective of the study is to compare the safety and efficacy of multiple formulations of BLI1100 to a control group and placebo in treating patients with moderate-severe acne vulgaris.